Financials
Income statement
Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
---|---|---|---|---|
Total reported revenue | 2.5B | 2.7B | 2.8B | 2.3B |
Cost of revenue | 1.7B | 1.9B | 1.9B | 1.6B |
Gross profit | 728M | 819M | 867M | 675M |
Operating expense | ||||
Research & development | 23M | 25M | 26M | 26M |
Selling general and admin | 378M | 421M | 425M | 370M |
Other operating expenses | — | — | — | — |
Operating income | 308M | 354M | 396M | 258M |
Non operating interest income | ||||
Income | 5M | 8M | 4M | 1M |
Expense | 85M | 88M | 87M | 84M |
Other income expense | -147M | -27M | -29M | -181M |
Pretax income | 81M | 247M | 284M | -6M |
Tax provision | 15M | 74M | 66M | -3M |
Net income | 66M | 173M | 218M | -3M |
Basic EPS | 0.2 | 0.6 | 0.7 | 0.0 |
Diluted EPS | 0.2 | 0.6 | 0.7 | 0.0 |
Basic average shares | 298M | 298M | 298M | 298M |
Diluted average shares | 299M | 299M | 301M | 298M |
EBITDA | 431M | 476M | 511M | 341M |
Net income from continuing op. | 66M | 173M | 218M | -3M |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | — | — | — | — |